AAAAAA

   
Results: 1-25 | 26-37
Results: 1-25/37
DETERMINANTS OF GD-ENHANCED MRI RESPONSE TO IFN-BETA-I A TREATMENT INRELAPSING-REMITTING MULTIPLE-SCLEROSIS
Authors: KOUDRIAVTSEVA T POZZILLI C FIORELLI M GASPERINI C BAGNATO F GALGANI S FRONTONI M CICCARELLI O BASTIANELLO S
Citation: T. Koudriavtseva et al., DETERMINANTS OF GD-ENHANCED MRI RESPONSE TO IFN-BETA-I A TREATMENT INRELAPSING-REMITTING MULTIPLE-SCLEROSIS, Multiple sclerosis, 4(5), 1998, pp. 403-407
ANTIINTERFERON (IFN) ANTIBODIES IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE-SCLEROSIS TREATED WITH RECOMBINANT IFN-BETA-1A OR IFN-BETA-1B
Authors: ANTONELLI G SIMEONI E BAGNATO F POZZILLI C CURRENTI M DIMARCO P TURRIZIANI O RIVA E GASPERINI C DIANZANI F FIESCHI C
Citation: G. Antonelli et al., ANTIINTERFERON (IFN) ANTIBODIES IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE-SCLEROSIS TREATED WITH RECOMBINANT IFN-BETA-1A OR IFN-BETA-1B, European cytokine network, 9(3), 1998, pp. 165-165
DEVELOPMENT OF NEUTRALIZING ANTIBODIES IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE-SCLEROSIS TREATED WITH IFN-BETA-1A
Authors: ANTONELLI G BAGNATO F POZZILLI C SIMEONI E BASTIANELLI S CURRENTI M DEPISA F FIESCHI C GASPERINI C SALVETTI M DIANZANI F
Citation: G. Antonelli et al., DEVELOPMENT OF NEUTRALIZING ANTIBODIES IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE-SCLEROSIS TREATED WITH IFN-BETA-1A, Journal of interferon & cytokine research, 18(5), 1998, pp. 345-350
A PRELIMINARY-STUDY COMPARING THE SENSITIVITY OF SERIAL MONTHLY ENHANCED MRI AFTER STANDARD AND TRIPLE DOSE GADOLINIUM-DTPA FOR MONITORING DISEASE-ACTIVITY IN PRIMARY PROGRESSIVE MULTIPLE-SCLEROSIS
Authors: FILIPPI M ROVARIS M GASPERINI C CAPRA R BASTIANELLO S KUHNE I YOUSRY TA
Citation: M. Filippi et al., A PRELIMINARY-STUDY COMPARING THE SENSITIVITY OF SERIAL MONTHLY ENHANCED MRI AFTER STANDARD AND TRIPLE DOSE GADOLINIUM-DTPA FOR MONITORING DISEASE-ACTIVITY IN PRIMARY PROGRESSIVE MULTIPLE-SCLEROSIS, Journal of neuroimaging, 8(2), 1998, pp. 88-93
CORRELATIONS BETWEEN MONTHLY ENHANCED MRI LESION RATE AND CHANGES IN T2 LESION VOLUME IN MULTIPLE-SCLEROSIS
Authors: MOLYNEUX PD FILIPPI M BARKHOF F GASPERINI C YOUSRY TA TRUYEN L LAI HM ROCCA MA MOSELEY IF MILLER DH
Citation: Pd. Molyneux et al., CORRELATIONS BETWEEN MONTHLY ENHANCED MRI LESION RATE AND CHANGES IN T2 LESION VOLUME IN MULTIPLE-SCLEROSIS, Annals of neurology, 43(3), 1998, pp. 332-339
SERUM AMYLOID-A PROTEIN IS ELEVATED IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS
Authors: RISTORI G LAURENTI F STACCHINI P GASPERINI C BUTTINELLI C POZZILLI C SALVETTI M
Citation: G. Ristori et al., SERUM AMYLOID-A PROTEIN IS ELEVATED IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS, Journal of neuroimmunology, 88(1-2), 1998, pp. 9-12
PLACEBO-CONTROLLED MULTICENTER RANDOMIZED TRIAL OF INTERFERON BETA-1BIN TREATMENT OF SECONDARY PROGRESSIVE MULTIPLE-SCLEROSIS
Authors: KAPPOS L POLMAN C POZZILLI C THOMPSON A DAHLKE F KNIGHT R HERN J COLEMAN R GERRIE L COOPER G MOORE J BORINGA J VANOOSTEN B RONNER H SCHRIJVER H TRUYEN L MONTALBAN J RIO J TINTORE M JACAS C MARZO E LECHNERSCOTT J HUBER S LIENERT C BRUNNSCHWEILER H HAWKINS S DROOGAN A MCDONNELL G DUDDY M MCKINSTRY S ALTENKIRCH H BAUM K EINHAUPL K MARX P POEWE W WALTER G AKMAN H BROCKMEIER B SCHERER P ZSCHENDERLEIN R SCHMIERER K GELDERBLOM H HARTMANN A STAPF C LUSCHOW A MACKERT B SCHUMACHER H MASUHR F HEMPEL T ZIMMERMANN R MUNCH M FRANCIS D HEAFIELD M ALMEMAR A WINER J CHONG M BROCHET B GAYOU A AURIACOMBE S DOUSSET V WILES C THOMAS F PICKERSGILL T HINDS N DAWSON K HUGHES T HUTCHINSON M MURPHY R REDMOND J WEBB S STOLL G JANDER S HAGEMANN G KOLLER H HANEMANN C KOLMEL H REICHEL D PETEREIT K THIEME A KHATAMI A NEUMANN M AMADUCCI L MASSACESI L SIRACUSA G AMATO M BARTOLOZZI L REPICE A MINDERHOUD J DEKEYSER J ZORGDRAGER A ZWANIKKEN C POSER S POLAK T GUNTHER A BITSCH A BORNER T WEBER F WIKSTROM J FARKKILA M MAJURI H SUMELAHTI M TELAKIVI T FREDRIKSON S MARTIN C MILLER D ORIORDAN J BREX P KAPOOR R WERRING D CONFAVREUX C BRUNET P HANNOUN D BRUDON F MOREAU T BLANC S DHOOGHE M JACOBS K LISSOIR F DEMONTY L COMI G COLOMBO B ROSSI P RODEGHER M SANTUCCIO G MARTINELLI F HOHLFELD R WALTHER E GOEBELS N DANG T LINDERT R VOLTZ R CARTLIDGE N BATES D MORAN G PANDIT L WESTWOOD M HALLER P SOMMER J BITTER J SUSS F MELLIES J MUCHA P LYONCAEN O DEGOS JD ROULLET E LUBETZKI C CREANGE A TOURBAH A PEZ D LECANUET P NICOLT P EDAN G BELLIARD S DEMARCO O CAHAGNE V DEBURGHGRAEVE V BRUNET I FIESCHI C MILLEFIORINI E GASPERINI C BUTTINELLI C FRONTINI M HOWELL S HADJIVASSILIOU M GIBSON A GRAHAM A HARKNESS K LAWDEN M CLANET M WAUBAN E AZAISVUILLEMIN C LAU G LOUIS C PANELIUS M RUUTIAINEN J ERALINNA J SOILUHANNINEN M GOLD R HARTUNG HP JUNG S BAYAS A FLACHENECKER P WEILBACH F ARCHELOS J KOLLEGGER H VASS K ASENBAUM S CHATSAKOS T BECKMANN K GHAZI M WAGNER K MILTENBURGER C MCFARLAND H PETKAU J SABOURAUD O TOYKA K
Citation: L. Kappos et al., PLACEBO-CONTROLLED MULTICENTER RANDOMIZED TRIAL OF INTERFERON BETA-1BIN TREATMENT OF SECONDARY PROGRESSIVE MULTIPLE-SCLEROSIS, Lancet, 352(9139), 1998, pp. 1491-1497
ANTINUCLEAR ANTIBODIES AND MRI ACTIVITY IN MULTIPLE-SCLEROSIS
Authors: POZZILLI C BASTIANELLO S GASPERINI C SALVETTI M
Citation: C. Pozzilli et al., ANTINUCLEAR ANTIBODIES AND MRI ACTIVITY IN MULTIPLE-SCLEROSIS, Neurology, 51(2), 1998, pp. 650-650
A COMPARISON OF THE SENSITIVITY OF MONTHLY UNENHANCED AND ENHANCED MRI TECHNIQUES IN DETECTING NEW MULTIPLE-SCLEROSIS LESIONS
Authors: ROCCA MA ROVARIS M BASTIANELLO S GASPERINI C POZZILLI C COMI G FILIPPI M
Citation: Ma. Rocca et al., A COMPARISON OF THE SENSITIVITY OF MONTHLY UNENHANCED AND ENHANCED MRI TECHNIQUES IN DETECTING NEW MULTIPLE-SCLEROSIS LESIONS, Neurology, 50(4), 1998, pp. 2073-2073
SERIAL STANDARD-DOSE AND TRIPLE-DOSE MRI TO MONITOR THE EFFECT OF INTERFERON BETA-1 A ON MULTIPLE-SCLEROSIS ACTIVITY
Authors: FILIPPI M ROVARIS M CAPRA R GASPERINI C MARTINELLI V SORMANI MP BASTIANELLO S COMI G
Citation: M. Filippi et al., SERIAL STANDARD-DOSE AND TRIPLE-DOSE MRI TO MONITOR THE EFFECT OF INTERFERON BETA-1 A ON MULTIPLE-SCLEROSIS ACTIVITY, Neurology, 50(4), 1998, pp. 37003-37003
EFFECT OF STEROIDS ON GD-ENHANCING LESIONS BEFORE AND DURING RECOMBINANT BETA-INTERFERON 1A TREATMENT IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS
Authors: GASPERINI C POZZILLI C BASTIANELLO S KOUDRIAVTSEVA T GALGANI S MILLEFIORINI E PAOLILLO A HORSFIELD MA BOZZAO L FIESCHI C
Citation: C. Gasperini et al., EFFECT OF STEROIDS ON GD-ENHANCING LESIONS BEFORE AND DURING RECOMBINANT BETA-INTERFERON 1A TREATMENT IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS, Neurology, 50(2), 1998, pp. 403-406
EFFECT OF TRAINING AND DIFFERENT MEASUREMENT STRATEGIES ON THE REPRODUCIBILITY OF BRAIN MRI LESION LOAD MEASUREMENTS IN MULTIPLE-SCLEROSIS
Authors: FILIPPI M GAWNECAIN ML GASPERINI C VANWAESBERGHE JH GRIMAUD J BARKHOF F SORMANI MP MILLER DH
Citation: M. Filippi et al., EFFECT OF TRAINING AND DIFFERENT MEASUREMENT STRATEGIES ON THE REPRODUCIBILITY OF BRAIN MRI LESION LOAD MEASUREMENTS IN MULTIPLE-SCLEROSIS, Neurology, 50(1), 1998, pp. 238-244
A LONGITUDINAL BRAIN MRI STUDY COMPARING THE SENSITIVITIES OF THE CONVENTIONAL AND A NEWER APPROACH FOR DETECTING ACTIVE LESIONS IN MULTIPLE-SCLEROSIS
Authors: FILIPPI M MASTRONARDO G BASTIANELLO S ROCCA MA ROVARIS M GASPERINI C POZZILLI C COMI G
Citation: M. Filippi et al., A LONGITUDINAL BRAIN MRI STUDY COMPARING THE SENSITIVITIES OF THE CONVENTIONAL AND A NEWER APPROACH FOR DETECTING ACTIVE LESIONS IN MULTIPLE-SCLEROSIS, Journal of the neurological sciences, 159(1), 1998, pp. 94-101
DETECTING NEW LESION FORMATION IN MULTIPLE-SCLEROSIS - THE RELATIVE CONTRIBUTIONS OF MONTHLY DUAL-ECHO AND T-1-WEIGHTED SCANS AFTER TRIPLE-DOSE GADOLINIUM
Authors: FILIPPI M MASTRONARDO G ROCCA MA CAPRA R GASPERINI C ROVARIS M BASTIANELLO S COMI G
Citation: M. Filippi et al., DETECTING NEW LESION FORMATION IN MULTIPLE-SCLEROSIS - THE RELATIVE CONTRIBUTIONS OF MONTHLY DUAL-ECHO AND T-1-WEIGHTED SCANS AFTER TRIPLE-DOSE GADOLINIUM, European neurology, 40(3), 1998, pp. 146-150
A MULTICENTER LONGITUDINAL-STUDY COMPARING THE SENSITIVITY OF MONTHLYMRI AFTER STANDARD AND TRIPLE DOSE GADOLINIUM-DTPA FOR MONITORING DISEASE-ACTIVITY IN MULTIPLE-SCLEROSIS - IMPLICATIONS FOR PHASE-II CLINICAL-TRIALS
Authors: FILIPPI M ROVARIS M CAPRA R GASPERINI C YOUSRY TA SORMANI MP PRANDINI F HORSFIELD MA MARTINELLI V BASTIANELLO S KUHNE I POZZILLI C COMI G
Citation: M. Filippi et al., A MULTICENTER LONGITUDINAL-STUDY COMPARING THE SENSITIVITY OF MONTHLYMRI AFTER STANDARD AND TRIPLE DOSE GADOLINIUM-DTPA FOR MONITORING DISEASE-ACTIVITY IN MULTIPLE-SCLEROSIS - IMPLICATIONS FOR PHASE-II CLINICAL-TRIALS, Brain (Print), 121, 1998, pp. 2011-2020
MRI EVOLUTION OF NEW MS LESIONS ENHANCING AFTER DIFFERENT DOSES OF GADOLINIUM
Authors: ROVARIS M MASTRONARDO G GASPERINI C PRANDINI F YOUSRY TA FILIPPI M
Citation: M. Rovaris et al., MRI EVOLUTION OF NEW MS LESIONS ENHANCING AFTER DIFFERENT DOSES OF GADOLINIUM, Acta neurologica Scandinavica, 98(2), 1998, pp. 90-93
MRI MEASURES AND THEIR RELATIONS WITH CLINICAL DISABILITY IN RELAPSING-REMITTING AND SECONDARY PROGRESSIVE MULTIPLE-SCLEROSIS
Authors: GIUGNI E POZZILLI C BASTIANELLO S GASPERINI C PAOLILLO A KOUDRIAVTSEVA T FRONTONI M FARINA D BOZZAO L
Citation: E. Giugni et al., MRI MEASURES AND THEIR RELATIONS WITH CLINICAL DISABILITY IN RELAPSING-REMITTING AND SECONDARY PROGRESSIVE MULTIPLE-SCLEROSIS, Multiple sclerosis, 3(4), 1997, pp. 221-225
4-YEAR FOLLOW-UP OF A CASE OF ACUTE MULTIPLE-SCLEROSIS OF THE MARBURGTYPE
Authors: GIUBILEI F SARRANTONIO A TISEI P GASPERINI C SALVETTI M
Citation: F. Giubilei et al., 4-YEAR FOLLOW-UP OF A CASE OF ACUTE MULTIPLE-SCLEROSIS OF THE MARBURGTYPE, Italian journal of neurological sciences, 18(3), 1997, pp. 163-166
QUANTITATIVE MAGNETIC-RESONANCE ANALYSIS IN VASCULAR DEMENTIA
Authors: GIUBILEI F BASTIANELLO S PAOLILLO A GASPERINI C TISEI P CASINI AR GRAGNANI A BOZZAO L FIESCHI C
Citation: F. Giubilei et al., QUANTITATIVE MAGNETIC-RESONANCE ANALYSIS IN VASCULAR DEMENTIA, Journal of neurology, 244(4), 1997, pp. 246-251
RANDOMIZED PLACEBO-CONTROLLED TRIAL OF MITOXANTRONE IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS - 24-MONTH CLINICAL AND MRI OUTCOME
Authors: MILLEFIORINI E GASPERINI C POZZILLI C DANDREA F BASTIANELLO S TROJANO M MORINO S MORRA VB BOZZAO A CALO A BERNINI ML GAMBI D PRENCIPE M
Citation: E. Millefiorini et al., RANDOMIZED PLACEBO-CONTROLLED TRIAL OF MITOXANTRONE IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS - 24-MONTH CLINICAL AND MRI OUTCOME, Journal of neurology, 244(3), 1997, pp. 153-159
FAST SPIN-ECHO AND FAST FLUID-ATTENUATED INVERSION-RECOVERY VERSUS CONVENTIONAL SPIN-ECHO SEQUENCES FOR MR QUANTIFICATION OF MULTIPLE-SCLEROSIS LESIONS
Authors: BASTIANELLO S BOZZAO A PAOLILLO A GIUGNI E GASPERINI C KOUDRIAVTSEVA T MILLEFIORINI E HORSFIELD MA COLONNESE C TONI D FIORELLI M POZZILLI C BOZZAO L
Citation: S. Bastianello et al., FAST SPIN-ECHO AND FAST FLUID-ATTENUATED INVERSION-RECOVERY VERSUS CONVENTIONAL SPIN-ECHO SEQUENCES FOR MR QUANTIFICATION OF MULTIPLE-SCLEROSIS LESIONS, American journal of neuroradiology, 18(4), 1997, pp. 699-704
INTERSCANNER VARIATION IN BRAIN MRI LESION LOAD MEASUREMENTS IN MS - IMPLICATIONS FOR CLINICAL-TRIALS
Authors: FILIPPI M VANWAESBERGHE JH HORSFIELD MA BRESSI S GASPERINI C YOUSRY TA GAWNECAIN ML MORRISSEY SP ROCCA MA BARKHOF F NIJEHOLT GJLA BASTIANELLO S MILLER DH
Citation: M. Filippi et al., INTERSCANNER VARIATION IN BRAIN MRI LESION LOAD MEASUREMENTS IN MS - IMPLICATIONS FOR CLINICAL-TRIALS, Neurology, 49(2), 1997, pp. 371-377
A MULTICENTER LONGITUDINAL-STUDY COMPARING THE SENSITIVITY OF ENHANCED BRAIN MRI AFTER THE INJECTION OF STANDARD AND TRIPLE DOSE GADOLINIUM-DTPA FOR DETECTING ACTIVE LESIONS IN MS
Authors: FILIPPI M ROVARIS M CAPRA R BASTIANELLO S PRANDINI F GASPERINI C MARTINELLI V CALORI G COMI G
Citation: M. Filippi et al., A MULTICENTER LONGITUDINAL-STUDY COMPARING THE SENSITIVITY OF ENHANCED BRAIN MRI AFTER THE INJECTION OF STANDARD AND TRIPLE DOSE GADOLINIUM-DTPA FOR DETECTING ACTIVE LESIONS IN MS, Neurology, 48(3), 1997, pp. 55005-55005
GADOLINIUM-ENHANCED MRI PREDICTS CLINICAL AND MRI DISEASE-ACTIVITY INRELAPSING-REMITTING MULTIPLE-SCLEROSIS
Authors: KOUDRIAVTSEVA T THOMPSON AJ FIORELLI M GASPERINI C BASTIANELLO S BOZZAO A PAOLILLO A PISANI A GALGANI S POZZILLI C
Citation: T. Koudriavtseva et al., GADOLINIUM-ENHANCED MRI PREDICTS CLINICAL AND MRI DISEASE-ACTIVITY INRELAPSING-REMITTING MULTIPLE-SCLEROSIS, Journal of Neurology, Neurosurgery and Psychiatry, 62(3), 1997, pp. 285-287
NO INCREASE OF SERUM AUTOANTIBODIES DURING THERAPY WITH RECOMBINANT HUMAN INTERFERON-BETA(1A) IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS
Authors: COLOSIMO C POZZILLI C FRONTONI M FARINA D KOUDRIAVTSEVA T GASPERINI C SALVETTI M VALESINI G
Citation: C. Colosimo et al., NO INCREASE OF SERUM AUTOANTIBODIES DURING THERAPY WITH RECOMBINANT HUMAN INTERFERON-BETA(1A) IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS, Acta neurologica Scandinavica, 96(6), 1997, pp. 372-374
Risultati: 1-25 | 26-37